Dietary flavonoid quercetin and associated health benefits-An overview

Food Reviews International

Volumn 26, Issue 3, 2010, Pages 302-317

  Jan, Arif Tasleem ^a   Kamli, Majid Rasool ^a   Murtaza, Imtiyaz ^b   Singh, Jang Bahadur ^c   Ali, Arif ^a   Haq, Q M R ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^b Biochemistry and Molecular Biotechnology Lab   (India)

^c GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Antioxidant; Phytochemicals; Quercetin

Indexed keywords

ANTI-OXIDANT ACTIVITIES; CHEMOTHERAPEUTIC AGENTS; DEGENERATIVE DISEASE; EPIDEMIOLOGICAL STUDIES; PHYTOCHEMICALS; QUERCETIN; TUMOR PROLIFERATION; XENOBIOTIC METABOLISM;

ANTIOXIDANTS; BIOCHEMISTRY; CELL DEATH; MEDICAL APPLICATIONS; NUTRITION; PHENOLS; SIGNAL TRANSDUCTION;

FLAVONOIDS;

ALLIUM CEPA;

EID: 77953483654     PISSN: 87559129     EISSN: 15256103     Source Type: Journal    
DOI: 10.1080/87559129.2010.484285     Document Type: Article

References (103)

1. Scalbert, A.; Johnson, I.; Saltmarsh, M. Polyphenols: Antioxidants and beyond. Am. J. clin. Nutr. 2005, 81, 215S-217S.
2. Hollman, P.C.; Katan, M.B. Absorption, metabolism and health effects of dietary flavonoids in man. Biomed. Pharmacother 1997, 51, 305-310.
3. Scalbert, A.; Williamson, G. Dietary intake and bioavailability of polyphenols. J Nutr. 2000, 130, 2073S-2085S.
4. Morand, C.; Crespy, V.; Manach, C.; Besson, C.; Demigne, C.; Remesy, C. Plasma metabolites of quercitin and their antioxidant properties. Am. J. Physiol. 1998, 275, R212-R219.
5. Formica, J.V.; Regelson, W. Review of biology of quercetin and related bioflavonoids. Food Chem. Toxicol. 1995, 33, 1061-1080.
6. Hertog, M.G.L.; Hollman, P.C.H.; Katan, M.B. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in Netherlands. J. Agric. Food Chem. 1992, 40, 2379-2383.
7. Ames, B.N.; Shigenaga, M.K.; Hagen T.M. Oxidants, antioxidants and degenerative diseases of Aging. Proc. Natl. Acad. Sci USA 1993, 90, 7915-7922.
8. David, R.F.; Smith, A.; Malkhandi, J.; Fyfe, D.W.; De-Takats, P.G.; Anderson, D.; Baker, J.; Kerr, D.J. Phase I clinical trails of the flavonoid Quercetin: Pharmacokinetics and evidence for in vivo Tyrosine Kinase inhibition. Clinical Cancer Research, 1996, 2, 659-668.
9. Yao, L.H.; Jiang, Y.M.; Shi, J.; Barberan, T.; Thomas-Barberan, F.A.; Datta, N.; Singanusong, R.; Chen, S.S. Flavonoids in food and their health benefits. Plant Foods for Human Nutrition, 2004, 59; 113-122.
10. Lakhanpal, P.; Rai, D.K., Quercetin: A versatile flavonoid. Internet Journal of Medical Update 2007, 2, 22-37.
11. Arts, I.C.; Hollman, P.C. Polyphenols and disease risk in epidemiological study. Am. J. Clin. Nutr. 2005, 81, 317S-325S.
12. Knekt, P.; Kumpulainen, J.; Jarvinen, R.; Rissanen, H.; Heliovaara, M.; Reunannen, A.; Halulinen, T.; Aromaa, A. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr, 2002, 76, 560-568.
13. Cao, G.; Sofic, E.; Prior, R. Antioxidant and Prooxidant behaviour of flavonoids; Structure-activity relationship. Free Rad. Biol. Med. 1997, 22, 749-760.
14. Hanasaki, Y.; Ogawa, S.; Fukui, S. Correlation between active oxygen scavenging and antioxidative effects of flavonoids. Free Rad. Biol. Med. 1994, 16, 845-850.
15. Tournaire, C., Croux, S., Maurette, M. T., Beck, I., Hocquaux, M., Braun, A.M., Olivers, E. Antioxidant activity of flavonoids; efficiency of singlet oxygen quenching. J Photochem Photo-biol, 1993, 19, 205-215.
16. Rice-Evans, C.A. Flavonoid antioxidants. Current Medicinal Chemistry 2001, 8, 797-807.
17. Day, A.J.; Bao, Y.; Morgan, M.R.; Williamson, G. Conjugation position of Quercetin glucuronides and effect on biological activity. Free Rad. Biol. Med. 2000, 29, 1234-1243.
18. Boersma, M.G.; Van-der, W.H.; Bogaards, J.; Boeren, S.; Vervoort, J.; Cnubben, N.H.P.; Van-Lersel, M.L.P.S.; Van-Bladeren, P.J.; Reitjens, I.M.C.M. Regioselectivity of phase II of metabolism luteolin and Quercetin by UDP-glucurosyl transferases. Chem Res Toxicol, 2002, 15, 662-670.
19. Block, G. A role for antioxidants in reducing cancer risk. Nutr. Rev. 1992, 50, 207-213.
20. Scalbert, C.; Manach, C.; Morand, C.; Remesy, C. Dietary polyphenols and prevention of diseases. Critical Reviews in Food Science and Nutrition 2005, 45, 287-306.
21. Gabor, M. Anti-inflamatory and antiallergic properties of flavonoids. Prog. Clin. Biol. Res. 1986, 213, 471-480.
22. Middleton, E. Effect of plant flavonoids on immune and inflammatory cell function. Adv. Exp. Med. Biol. 1998, 439, 175-182.
23. Mata, R.; Rojas, A.; Acevedo, L.; Estrada, S.; Calzada, F.; Rojas, I.; Bye, R.; Linares, E. Smooth muscle relaxing flavonoids and terpenoids from Conyza filaginoides. Planta Med, 1997, 63, 31-35.
24. Yannai, S.; Day, A.J.; Williamson, G.; Rhodes, M.J. Characterization of flavonoids as mono-functional or bifunctional inducers of quinone reductase in murine hepatoma cell lines. Food Chem. Toxicol. 1998, 36, 623-630.
25. Boyer, J.; Liu, R.H. Apple phytochemicals and their health benefits. Nutrition Journal 2004, 3, 1-15.
26. Corthesy-Theulaz, I.; Dunnen, J.T.; Ferre, P.; Geurts, J.M.; Muller, M.; Van-Belzen, N.; Van-Ommen, B. Nutrigenomics: Impact of biomics technology on nutrition research. Annals of Nutrition and Metabolism, 2005, 49, 355-365.
27. Mutch, D.M.; Wahli, W.; Williamson, G. Nutrigenomics and Nutrigenetics: Emerging face of Nutrition. FASEB Journal 2005, 19, 1602-1616.
28. Muller, M.; Kersten, S. Nutrigenomics; goals and Strategies. Nat. Rev. Gen. 2003, 4, 315-322.
29. Mariman, E.C.M. Nutrigenomics and Nutrigenetics: the 'omics' revolution in nutritional science. Biotech. Appl. Biochem. 2006, 44, 119-128.
30. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: Food sources and Bioavailability. Am. J. Clin. Nutr. 2004, 79, 727-747.
31. Day, A.J.; Canada, F.J.; Diaz, J.C.; Kroon, P.A.; McLauchlan, R.; Faulds, C.B.; Plumb, G.W.; Morgan, M.R.; Willianson, G. Dietary flavonoid & isoflavone glycosides are hydrolyzed by lactase site of lactase phlorizin hydrolase. FEBS Lett, 2000, 468, 166-170.
32. Crespy, V.; Morand, C.; Besson, C.; Manach, C.; Demigne, C.; Remesy, C. Quercetin, but not its glycosides is absorbed from rat stomach. J Agric Food Chem, 2002, 50, 618-621.
33. Hollman, P.C.; De-Vries, J.H.; Van-Leeuwen, S.D.; Mengelers, M.J.; Katan M.B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 1995, 62, 1276-1282.
34. Erlund, I.; Kosonen, T.; Alfthan, G.; Maenpaa, J.; Perttunen, K.; Kenraali, J.; Parantanen, J.; Aro, A. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol, 2000, 56, 545-553.
35. Graefe, E.U.; Wittig, J.; Mueller, S.; Riethling, A.K.; Uehleke, B.; Drewelow, B.; Pforte, H.; Jacobasch, G.; Derendorf, H.; Veit, M. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol, 2001, 41, 492-499.
36. Hollman, P.C.; Van-Trijp J.M.; Buysman, M.N.; Van-der, G.M.S.; Mengelers, M.J.; DeVries, J.H.; Katan, M.B. Relative bioavailability of the antioxidant flavonoid quercitin from varios foods in man. FEBS Lett, 1997, 418, 152-156.
37. Nemeth, K.; Plumb, G.W.; Berrin, J.G.; Juge, N.; Jacob, R.; Naim, H.Y.; Williamson, G.; Swallow, D.M.; Kroon, P.A. Deglycosylation by small intestinal epithelial cell b-glucosidases is a critical step in the absorption & metabolism of dietary flavonoid glycosides in humans. Eur J Nutr, 2003, 42, 29-42.
38. Sesink, A.L.; Arts, I.C. Faassen-Peters, M., Hollman P. C., Intestinal uptake of Quercitin-3-glucoside in rat liver involves hydrolysis by lactose phlorizin hydrolase. J. Nutr. 2003, 133, 773-776.
39. Arts, I.C.; Sesnik, A.L.; Hollman, P.C. Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across brush border membrane of rat small intestines. J. Nutr. 2002, 2823.
40. Gee, J.M.; DuPont, M.S.; Rhodes, M.J.; Johnson, I.T. Quercetin glucosides interact with intestinal glucose transport pathway. Free Rad. Biol. Med. 1998, 25, 19-25.
41. Wolffram, S.; Block, M.; Ader, P. Quercetin-3-glucoside is transported by the glucose carrier SGLT 1 across the brush border membrane of rat small intestine. J Nutr. 2002, 132, 630-635.
42. Day, A.J.; DuPont, M.S.; Ridley, S.; Rhodes, M.; Rhodes, M.J.; Morgan, M.R.; Williamson, G. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestines and liver b-glucosidase activity. FEBS Lett, 1998, 436, 71-75.
43. Day, A.J.; Gee, J.M.; DuPont, M.S.; Johnson, I.T.; Williamson, G. Absorption of quercitin-3-glucoside and quercetin-4′-glucoside in the rat small intestine: role of lactase phlorizin hydrolase & sodium dependent glucose transporter. Biochem. Pharmacol. 2003, 65, 1199-1206.
44. Walgren, R.A.; Karnaky, K.J.; Lindenmayer, G.E.; Walle, T. Efflux of dietary flavonoid quercetin4′-glucoside across human intestinal caco-2 cell monolayers by apical multidrug resistance associated protein-2. J. Pharmacol. Exp. Ther. 2000, 294, 830-836.
45. Aura, A.M.; O'Leary K.A.; Williamson, G.; Ojala, M.; Bailey, M.; Puupponenpimia, R.; Nuutila, A.M.; Oksman-Caldentry, K.M.; Poutanen, K. Quercetin derivates are deconjugated & converted to hydroxyphenylacetic acid but not methylated by human fecal flora in vitro. J Agric Food Chem, 2002, 50, 1725-1730.
46. Kim, D.H.; Jung, E.A.; Sohng, I.S.; Han, J.A.; Kim, T.H.; Han, M.J. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch Pharm Res, 1998, 21, 17-23.
47. Hackett, A.M. Metabolism of flavonoid compounds in mammals. Prog. Clin. Biol. Res. 1986, 213, 177-194.
48. Oliveira, E.J.; Watson, D.G.; Grant M.H. Metabolism of quercetin and kaempferol by rat hepatocytes and identification of flavonoid glycosides in human plasma. Xenobiotica 2002, 32, 279-287.
49. Pietta, P.G. Flavonoids as antioxidants. J. Nat. Prod. 2000, 63, 1035-1042.
50. Canivenc-Lavier, M.C.; Vernevaut, M.F.; Totis, M.; Siess, M.H.; Magdalou, J.; Suschetet, M. Comparative effects of flavonoids and model inducers on drug metabolizing enzymes in rat liver. Toxicology 1996, 114, 19-27.
51. Storz, P. Reactive oxygen species in Tumor Progression. Front Biosci. 2005, 10, 1881-1896.
52. Nishigori, C.; Hattori, Y.; Toyokuni, S. Role of reactive oxygen species in skin carcinogenesis. Antioxid. Redox. Signal 2004, 6, 561-570.
53. Middleton, E.J.; Kandaswami, C.; Theoharides, T.C. Effect of plant flavonoids on Mammalian cells; implications for inflammation, heart diseases and cancer. Pharmacol. Rev.2000, 52, 673-651.
54. Talalay, P.; De-Long, M.J.; Prochaska, H.J. Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc. Natl. Acad. Sci. USA 1988, 85, 8261-8265.
55. Kim, D.H.; Jin, Y.H.; Park, J.B.; Kobashi, K. Silymarin and its components are inhibitors of b-glucuronidase. Biol. Pharm. Bull. 1994, 17, 443-445.
56. Laughton, M.J.; Evans, P.J.; Moroney, M.A.; Hoult, J.R.; Halliwell, B. Inhibition of mammalian 5-lipoxygenase and cycloxygenase by flavonoids and phenolic dietary additives; relationship to antioxidant activity to iron ion reducing ability. Biochem. Pharmacol. 1991, 42, 1673-1681.
57. Schewe, T.; Kuhn, H.; Sies, H. Flavonoids of cocoa inhibits recombinant human 5-lipoxygenase. Nutrition J. 2002, 132, 1825-1829.
58. Raso, G.M.; Meli, R.; Di-Carlo, G.; Pacilio, M.; DiCarlo, R. Inhibition of inducible nitric oxide synthase and cycloxygenase-2 expression by flavonoids in macrophage J774A. Life Sci. 2001, 68, 921-931.
59. Siess, M.H.; Leclerc, J.; Canivenc-Lavier, M.C.; Rat, P.; Suschetet, M. Heterogenous effect of natural flavonoids on monoxygenase activities in human and rat liver microsomes. Toxicol. Appl. Pharmacol. 1995, 130, 73-78.
60. Doerge, D.R.; Chang, H.C. Inactivation of thyroid peroxidase by Soy isoflavones, in vitro and in vivo. J. Biomed. Life Sci. 2002, 777, 269-279.
61. Sheu, S.Y.; Lai, C.H.; Chiang, H.C. Inhibition of xanthine oxidase by Purpurogallin and Silymarin group. Anticancer Res. 1998, 18, 263-267.
62. Cushman, M.; Nagarathnam, D.; Burg, D.L.; Geahlen, R.L. Synthesis and protein Tyrosine Kinase inhibitory activities of Flavonoid analogues. J. Med. Chem. 1991, 34, 798-806.
63. Wood, A.W.; Smith, D.S.; Chang, R.L.; Huang, M.T.; Conney, A.H. Effects of flavonoids on the metabolism of Xenobiotics. Prog.Clin. Biol. Res. 1986, 213, 195-210.
64. Young, J.M.; Wang, X.; Morris, M.E. Dietary flavanoid; Effect on Xenobiotic and Carcinogen metabolism. Toxicology in vitro 2006, 20, 187-210.
65. Valerio, L.G.; Kepa, J.K.; Pickwell, G.V.; Quattrochi, L.C. Induction of human NAD(P)H; quinine oxidoreductase (NQO1) gene expression by the flavanol quercetin. Toxicol Lett. 2001, 119, 49-57.
66. Schwarz, D.; Kisselev, P.; Roots, I. CYP1A genotype selective inhibition of benzopyrene activation by Quercetin. Eur. J. Cancer 2005, 41, 151-158.
67. Walle, T.; Eaton, A.; Walle, U.K. Quercetin, a potent and specific inhibitor of human p-form phenol sulfotransferase. Biochem. Pharmacol. 1995, 50, 731-734.
68. Otake, Y.; Nolan, A.L.; Walle, U.K.; Walle, T. Quercetin and reversatol potentially reduce estrogen sulfotransferase activity in normal human mammary epithelial cells. J. Ster. Biochem. Mol. Biol. 2000, 63, 265-270.
69. Walsky, R.L.; Gaman, E.A.; Obach, R.S. Examination of 209 drugs for inhibition of cytochrome P450. J. Clin. Pharmacol. 2005, 45, 68-78.
70. Talalay, P.; Fahey, J.W.; Holtzclaw, W.D.; Prestera, T.; Zhang, Y. Chemoprotection against cancer by phase 2 enzyme induction. Toxicol. Lett. 1995, 82-83, 173-179.
71. Manson, M.M.; Farmer, P.B.; Gescher, A.; Steward, W.P. Innovative Agents in Cancer Prevention. Tumor Prevention and Genetics III 2005, 166, 257-275.
72. Yee, K.S.; Vousden, K.H. Complicating the complexity of p53. Carcinogenesis 2005, 26, 1317-1322.
73. Mu C.; Jia, P.; Yan, Z.; Liu, X.; Li, X.; Liu, H. Quercetin induces cell-cycle G1 arrest through elevating Cdk inhibitors p21 and p27 in human hepatoma cell line (HepG2). Methods Find Exp. Clin. Pharmacol. 2007, 29 (3), 179.
74. Neto, C.C. Cranberry and Its Phytochemicals: A Review of In Vitro Anticancer Studies Nutrition J. 2007, 137, 186S-193S.
75. Duthie, S.J.; Johnson, W.; Dobson, V.L. Effect of Dietary flavonoids on DNA damage (Strand breaks and oxidized pyrimidines) and growth in human cells. Mut. Res. 1997, 390, 141-151.
76. Balabhadrapathruni, S.; Thomas, T.J.; Yurkow, E.J.; Amenta, P.S.; Thomas, T. Effects of genistein and structurally related phytoestrogens on cell cycle kinetics & apoptosis in MDA-MB-468 human breast cancer cells. Oncol. Rep. 2000, 7, 3-12.
77. Murtaza, I.; Marra, G.; Schlapbach, R.; Patrignani, A.; Kunzli, M.; Wagner, U.; Sabates, J.; Dutt, A. Preliminary investigation demonstrating the effect of Quercitin on the expression of genes related to cell cycle arrest, apoptosis & Xenobiotic metabolism in human CO115 colon adrenocarcinoma cells using DNA microarray. Biotech. Appl. Biochem, 2006, 45, 29-36.
78. Agullo, G.; Gamet-Payrastre, L.; Manenti, S.; Viala, C.; Remesy, C.; Chap, H.; Payrastre, B. Relationship between flavonoid structure & inhibition of phosphatidylinositol-3-kinase; a comparison with Tyrosine kinase & protein kinase C inhibition. Biochem Pharmacol, 1997, 53, 1649-1657.
79. Matter, W.F.; Brown, R.F.; Vlahos, C.J. The inhibition of phosphatidylinositol-3-kinase by Quercetin and Analogs. Biochem. Biophys. Res. Commun. 1992, 186, 624-631.
80. Arai, N.; Strom, A.; Rafter, J.J.; Gustafsson, J.A.b-Estrogen receptor mRNA in colon cancer cells; growth effects of estrogen & genistin. Biochem. Biophys. Res. Commun. 2000, 270, 425-431.
81. Van-der, W.H.; Gliszczynska-Swiglo, A.; Struijs, K.; Smeets, A.; Alink, G.M.; Rietjens, I.M. Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans. Cancer Letters 2003, 200, 41-47.
82. Jacobs, M.N.; Lewis, D.F. Steroid hormone receptors & dietary ligands; A selected review. Proc. Nutr. Soc. 2002, 61, 105-122.
83. Benassayag, C.; Perrot-Applanat, M.; Ferre, F. Phytoestrogens as modulators of steroid action in target cells. J. Biomed. Life Sci. 2002, 777, 233-248.
84. Hall, J.M.; McDonnell, D.P. Estrogen receptor beta-isoform (ER-b) of human estrogen receptor modulates ER-a transcriptional activity & as key regulator of cellular response to estrogen and antiestrogens. Endocrinology 1999, 140, 5566-5578.
85. Walgren, R.A., Karnaky, K.J., Lindenmayer, G.E., Walle, T. Efflux of Dietary Flavonoid Quercetin 4́-b-Glucoside across Human Intestinal Caco-2 Cell Monolayers by Apical Multidrug Resistance-Associated Protein-2. Journal of Pharmacology and Experimental Therapeutics 2000, 294, 830-836.
86. Hertog, M.G.; Feskens, E.J.; Hollman, P.C.H.; Katan, M.B.; Kromhout, D. Dietary flavonoids and risk of coronary heart diseases. Lancet 1993, 342, 1007-1011.
87. Knekt, P.; Jarvinen, R.; Reunanen, A.; Maatela, J.; Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 1996, 312, 478-481.
88. Manach, C.; Mazur, A.; Scalbert, A. Polyphenols and prevention of cardiovascular diseases. Current opinion in lipidology 2005, 16, 1-10.
89. DeSilva, E.L.; Tsushida, T.; Terao, J. Inhibition of mammalian 15-lipoxygenase dependent lipid peroxidation in low-density lipoprotein by quercetin and quercetin glucosides. Arch Biochem. Biophys. 1998, 349, 313-320.
90. Floyd, R.A. Antioxidants, oxidative stress and degenerative neurological disorders. Exp. Biol. Med. 1999, 222, 236-245.
91. Heo, H.J.; Lee, C.Y. Protective effects of Quercetin and Vitamin C against Oxidative Stress-Induced Neurodegeneration. J. Agric. Food Chem. 2004, 52, 7514-7517.
92. Saag, K.G.; Choi H. Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Research & Therapy 2006, 8 (Suppl-1), S2.
93. Nuki, G.; Simkin, P.A. Concise history of gout and hyperuricemia and their treatment Arthritis Research & Therapy 2006, 8 (Suppl-1), S1.
94. Mo, S.F.; Zhou, F.; Yao-Zhong, L.V.; Qing-Hua, H.U.; Zhang, D. M.; Kong, L. D. Hypouricemic Action of Selected Flavonoids in Mice: Structure-Activity Relationships. Biol. Pharm. Bull. 2007, 30 (8), 1551-1556.
95. Wojtczak, L.; Schonfeld, P. Effect of fatty acids on energy coupling processes in mitochondria. Biochem. Biophys. Acta 1993, 1183, 41-57.
96. King, G.L.; Loeken, M.R. Hyperglycemia induced oxidative stress in diabetic complications. Histochem. Cell Biol. 2004, 122, 333-338.
97. Griendling, K.K.; Fitzgerald, G.A. Oxidative stress and cardiovascular injury; Basic mechanisms and In vivo monitoring of ROS. Circulation 2003, 108, 1912-1916.
98. Anjaneyulu, M.; Chopra, K. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clinical and Experimental Pharmacology and Physiology 2004, 31 (4), 244-248.
99. MacGregor, J.T.; Jurd, L. Mutagenecity of plant flavonoids; Structural requirements for mutagenic activity in Salmonella Typimurium. Mut. Res. 1978, 5, 297-309.
100. Nagao, M.; Morita, N.; Yahagi, T.; Shimizu, M.; Kuroyanagi, M.; Fukuoka, M.; Yoshihira, K.; Natori, S.; Fujino, T.; Sugimura, T. Mutagenecities of 61 flavonoids and 11 related compounds. Env Mut, 1981, 3, 401-419.
101. Silva, I.D.; Gaspar, J.; DeCosta, G.G.; Rodrigues, A.S.; Laires, A.; Rueff, J. Chemical features of flavonols affecting their genotoxicity; Potential implications in their use as therapeutical agents. Chem. Biol. Interact. 2000, 124, 29-51.
102. Vander, H.J.C.; Bruggeman, I.M.; Debets, F.M. Genotoxicity of quercetin in cultured mammalian cells. Mut. Res. 1984, 136, 9-21.
103. Vrijsen, R.; Michotte, Y.; Boeye, A. Metabolic activation of quercetin mutagenecity. Mut. Res. 1990, 232, 243-248.